Acrylamide is a reproductive toxicant that has been detected in foods such as potato chips and breads. The consequences of chronic exposure to acrylamide in the human diet are unknown; however, rodent experiments have shown that acute acrylamide exposure in males can lead to decreased fertility and dominant lethality. One of the possible mechanisms by which acrylamide elicits these effects is thought to be related to its metabolic conversion to glycidamide, which can form DNA adducts. To determine whether chronic acrylamide exposure produces genetic damage in male germ cells in vivo, male mice were subjected to acrylamide through their drinking water. Acrylamide was administered at 0.001, 0.01, 0.1, 1, and 10 µg/ml for up to 1 year, which was equivalent to 0.0001-2 mg/kg bodyweight/day. At 1, 3, 6, 9, and 12 months, early male germ cells were assessed for DNA damage using a Comet assay modified to detect adducts and γH2A.X expression, a marker of double-strand breaks. Acrylamide treatment did not significantly affect mouse or testis weight, and no gross morphological effects were observed in the testis. However, a significant dose-dependent increase in DNA damage was observed in germ cells following 6 months of exposure in the two highest dosage groups (1 and 10 µg/ml). After 12 months of exposure, increases in damage were detected at doses as low as 0.01 µg/ml (0.001 mg/kg bodyweight/day). The results of this study are the first to demonstrate that chronic exposure to acrylamide, at doses equivalent to human exposures, generates DNA damage in male germ cells of mice.
For decades acrylamide has been used for the production of polyacrylamide, which has various industrial applications in water treatment, cosmetics, soil conditioning, and biomolecular laboratories for use in gel electrophoresis (Parzefall, 2008) . Exposure to acrylamide was previously thought to occur through industrial activities or through cigarette smoking, as the compound is also found in tobacco smoke. It is now known that acrylamide forms in numerous baked or fried carbohydrate-rich foods, particularly in plant-based products such as potato chips, crisps, breads, and coffee (Tareke et al., 2002) . These findings heightened concerns regarding widespread human exposure, as acrylamide is a known neurotoxicant in humans. Additionally, animal studies have demonstrated that acrylamide also acts as a genotoxin, carcinogen, and reproductive toxin; however, to date, epidemiological studies have not established a causative relationship between these effects and acrylamide exposure in humans (FAO/WHO, 2003) .
The reproductive effects of acrylamide have been observed in numerous rodent studies, with acute doses resulting in reduced fertility, embryo implantation losses, and reduced postnatal survival (Tyl and Friedman, 2003) . However, limited data are available regarding the consequences of long-term, low-level acrylamide exposure on reproductive health at doses relevant to the human situation. According to the 72nd report on Food additives by the Food and Agriculture Organization and World Health Organization, the average dietary intake of acrylamide was estimated to be 1 µg/kg bodyweight/day, or 4 µg/kg bodyweight/day for high consumers (WHO, 2011) . Although these estimates generally do not account for acrylamide exposure via drinking water or cosmetics, this level of exposure is considerably lower than doses known to induce acrylamide toxicity in animal studies. For example, the no observable adverse effect level (NOAEL) for acrylamide reproductive toxicity is considered to be 2-5 mg/kg bodyweight/day, depending on the endpoint of fertility or embryonic death (Exon, 2006) . Hence, dietary acrylamide exposure is considered unlikely to induce reproductive toxicity in humans.
However, there are concerns that long-term exposure to the compound may have cumulative effects. Indeed the neurotoxicity of acrylamide, characterized by hind-limb foot splay, ataxia, and skeletal muscle weakness, develops progressively. Following long exposure periods (60 days to 2 years), low doses of acrylamide have been documented to produce neurotoxic effects comparable to those observed in animals exposed at acute doses for shorter durations (10-30 days) (Lopachin and Gavin, 2008) . Chronic carcinogenic studies have been carried out in rats over 2 years at 0.1-2 mg/kg bodyweight/day, in which high doses resulted in increased tumor incidences in certain tissues (Friedman et al., 1995; Johnson et al., 1986) . To our knowledge, however, the reproductive toxicity of acrylamide has not been examined at doses less than 0.5 mg/kg bodyweight/day, nor for more than 6 months of exposure (Erkekoglu and Baydar, 2010; Tyl and Friedman, 2003) .
Evidence from previous studies indicates that reproductive toxicity of acrylamide primarily manifests in the male. In a study by Sakamoto and Hashimoto (1986) , acrylamide exposure in male mice (19 mg/kg bodyweight/day for 8 days) mated to unexposed females lead to increased incidences of embryo resorptions and reduced fertility rates. Other effects of acrylamide on male reproduction include decreased reproductive behavior, testicular atrophy, abnormal spermatogenesis, and reduced sperm quality (Hashimoto et al., 1981; Sublet et al., 1989; Wise et al., 1995; Yang et al., 2005) . The mechanisms by which acrylamide elicits these effects have not been fully elucidated. However, studies in cyp2e1 knockout mice indicate that the cytochrome P450, cyp2e1, may be essential in mediating acrylamide reproductive toxicity (Ghanayem et al., 2005b,c) . CYP2E1 specifically metabolizes acrylamide to the epoxide, glycidamide, which can form DNA adducts and cause DNA damage. DNArepair mechanisms are limited in male germ cells during late spermatogenesis (Jansen et al., 2001; Olsen et al., 2005) ; hence, unresolved genetic damage in these cells may impact on downstream fertilization and the health of future progeny.
Although levels of acrylamide in the human diet may not induce overt reproductive toxicity, chronic exposure could generate DNA damage in the male germ line due to the indirect genotoxicity of acrylamide via glycidamide. Thus, we conducted a chronic 12-month exposure experiment in which acrylamide was administered to male mice at a low-level range of 0.1 µg-2 mg/kg bodyweight/day via the drinking water. Genetic lesions in the form of DNA adducts and double-strand breaks (DSBs) were assessed in enriched spermatocytes from exposed animals using a modified version of the Comet assay and a meiotic spread method. In this study, we report an accumulation of genetic damage in male germ cells of mice following 6-12 months of exposure, at doses relevant to human exposure.
MATERIALS AND METHODS
Chemicals and reagents. All chemicals and reagents were obtained from Sigma (St Louis, MO) unless otherwise stated and were of molecular biology or research grade. Dulbecco's modified Eagle's media (DMEM), supplemented with 1% v/v L-glutamine 200mM, 1% v/v sodium pyruvate 100mM, 2% v/v HEPES solution 1M, and 1% v/v penicillin streptomycin solution were obtained from Sigma and Invitrogen (Carlsbad, CA). Mini complete protease inhibitor cocktail tablets were purchased from Roche (Mannheim, Germany), and Halt phosphatase inhibitor cocktail was purchased from ThermoFisher Scientific (Rockford). DNA-repair endonuclease, formamidopyrimidine-DNA glycosylase (FPG) was purchased from New England Biolabs Inc. (Arundel, QLD). Primary antibodies, rabbit polyclonal anti-SCP3 (anti-SCP3, ab15093) and mouse monoclonal anti-γ H2A.X (phospho S139) (anti-γ H2A.X, ab18311), were obtained from Abcam (Cambridge, MA). Alexa Fluor 594 goat anti-rabbit (A11012) and Alexa Fluor 488 goat anti-mouse (A11001) immunoglobulin G (IgG) were purchased from Invitrogen.
Animals.
Experimental procedures involving animals were conducted in accordance with the policies set out by the Animal Care and Ethics Committee of the University of Newcastle (Ethics Number: SR A-2009-121). Male Swiss FIG. 1. Experimental design. Acrylamide was administered to male mice through the drinking water at concentrations of 0.001, 0.01, 0.1, 1, or 10 µg/ml, and animals were exposed for a period of 1, 3, 6, 9, or 12 months (i.e., 30 treatment groups). Six individuals were allocated to each treatment group, totaling 180 mice. Mouse bodyweight and water consumption were monitored throughout the duration of the study. The testes from three males were used for early germ cell isolation (see Materials and Methods section). Testes from the remaining three males were fixed and sectioned for histological analysis and immunohistochemistry. mice were 5-6 months old at the beginning of the study and ranged in weight from 31 to 55 g. All animals were housed under controlled temperature and humidity conditions, 16 h light, 8 h dark, with food and water provided ad libitum. Animals were acclimated for at least 1 month prior to treatment.
Experimental design. One hundred and eighty male mice were randomly distributed into 30 different treatment groups (six doses of acrylamide at five different time points). Six males were assigned to each group to ensure three replicates for each experimental endpoint (Fig. 1) . Testes from three males were used for germ cell isolation, and the testes from the remaining three males were used for either tissue sectioning (in which testes were fixed in Bouin's fixative, embedded in paraffin wax, and sectioned at 5 µm thickness) or protein extraction. Up to six individuals were housed in one cage, and all mice were monitored for signs of neurotoxicity or other adverse effects for the duration of treatment. Mouse bodyweight (Table 1 ) and water consumption (Supplementary table 1) were recorded every second day. It was established after 3 months that treatment did not significantly affect water consumption or bodyweight, and these parameters were monitored on a weekly basis for the remainder of the experiment. These records were used to calculate the average daily acrylamide dose and total cumulative dose administered to each treatment group (Table 2) .
Acrylamide treatment. Acrylamide drinking water solutions were prepared using research-grade acrylamide obtained from Sigma (≥ 99% purity, A9099) diluted in filtered, deionized water at concentrations 0.001, 0.01, 0.1, 1, and 10 µg/ml. Drinking water containing acrylamide was prepared fresh on a weekly basis, as the compound is stable in water for at least 1 week (Mei et al., a There were six mice in each treatment group. b Daily acrylamide dose was calculated using total water consumption for each mouse, multiplied by acrylamide concentration, divided by mouse weight immediately after treatment, and divided by the number of days exposed. Values presented as mean daily dose (mg/kg bodyweight/day). c Mice in the 0.01 µg/ml treatment group received a daily acrylamide dose equivalent to human exposure levels (0.001 mg/kg bodyweight/day; WHO, 2011). d Cumulative dose was calculated using total water consumption for each mouse, multiplied by acrylamide concentration, and divided by mouse weight immediately after treatment. Values presented as mean cumulative dose (mg/kg bodyweight).
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2008; Wang et al., 2010) , and was substituted for normal drinking water at the commencement of treatment. Test animals were exposed to acrylamide via the drinking water for a period of 1 month (4 weeks exactly), 3 months (12 weeks ± 1 week), 6 months (24 weeks ± 1 week), 9 months (36 weeks ± 1 week), or 12 months (48 weeks ± 1 week). Scheduled culling time points were staggered over a 3-week period (hence ± 1 week) for logistical purposes. However, this staggering was deemed inappropriate for the 1-month time point, as this treatment was only a 4-week period. Therefore, the timing of the 1-month time point was co-ordinated specifically to achieve exactly 4 weeks of exposure. Immediately after treatment, animals were euthanized by CO 2 asphyxiation, and tissues were collected.
Early germ cell isolation. Testes collected from all mice were weighed and spermatocytes were extracted using density sedimentation as described previously (Baleato et al., 2005) . Briefly, testes were disassociated and seminiferous tubules were digested sequentially with 0.5 mg/ml collagenase/DMEM and 0.5% trypsin/EDTA to remove extratubular contents and interstitial cells. Remaining cells were loaded onto a 2-4% bovine serum albumin (BSA)/ DMEM gradient to separate male germ cell types according to density. Germ cell fractions were collected, washed, and counted. This method enables the enrichment of germ cells with very little to no somatic cell contamination, as extratubular cells are digested and removed prior to density sedimentation. A purity of 65-70% can be obtained for pachytene spermatocyte isolations, with contaminating cells consisting of other germ cells, mostly early spermatocytes (Baleato et al., 2005) .
Comet assay. DNA damage in isolated spermatocytes was measured using an alkaline Comet assay according to methods published by Singh et al. (1988) with modifications as follows. Isolated germ cells suspended in PBS (1 × 10 7 cells/ml) were mixed with 0.5% low-melting point agarose and layered onto fully frosted Dakin slides (ProSciTech, Australia), precoated with 1% normal melting point agarose. Agarose was allowed to solidify at 4°C for 30 min and were immersed in fresh lysis solution (2.5M NaCl, 100mM Na 2 EDTA, 10mM Trizma, and 1% Triton X-100, pH 10) for 1 h at 4°C. Cells were incubated in lysis buffer with dithiothreitol (10mM final concentration) for a further 30 min at 4°C, after which lithium diiododsalicylate was added (4mM final concentration) and incubated for 1.5 h at room temperature. Following lysis, cells were treated with adduct specific cleavage enzyme, FPG, for 30 min at 37°C. All samples were incubated in chilled alkaline electrophoresis buffer (1mM EDTA, 0.3M NaOH) for 20 min. Electrophoresis was carried out for 5 min (25 V, 300 mA), and slides were drained and neutralized (0.4M Tris, pH 7.5). Slides were stained with 20 µg/ml ethidium bromide and visualized under fluorescence. The DNA integrity of 50-100 cells per slide was analyzed using Comet Assay IV software (Perceptive Instruments, Suffolk, U.K.). The fluorescence intensity in the comet "tail" was used as measure of DNA damage (tail DNA%). Mean Tail DNA was expressed as the percentage increase in damage relative to control samples to enable comparison of data between measurements across all time points (Fig. 3) . Highly damaged cells with irregular or blown out nuclei, also referred to as "clouds" or "hedgehogs," were excluded from analysis.
Immunohistochemistry. Mouse testes were fixed in Bouin's fixative, embedded in paraffin wax, and sectioned at 5-µm thickness. Sections were deparaffinized and rehydrated, and antigen retrieval was performed by microwaving sections for 3 × 3 min in 50mM Tris-HCl (pH 10). Sections were blocked in 3% BSA/PBS with 0.05% Tween-20 (PBST) for 1 h at room temperature, after which they were incubated with anti-γH2A.X (1:500 with 1% BSA/ PBST) overnight at 4°C. Sections were washed and incubated with fluorescentconjugated secondary antibody, Alexa Fluor 594 goat anti-rabbit IgG (1:200 with 1% BSA/PBST) for 1 h at room temperature. Counterstaining was conducted using the DNA-specific fluorochrome 4,6-diamidino-2-phenylindole (DAPI) for 3 min. Slides were mounted in Mowiol and observed under fluorescence on an Axio Imager A1 fluorescence microscope (Carl Zeiss MicroImaging Inc., Thornwood, NY). Images were taken using an Olympus DP70 microscope camera (Olympus America, Center Valley, PA).
Meiotic spreads. DNA damage in the form of DSBs was further examined in spermatocytes from mice subjected to 12 months of acrylamide exposure. In order for all samples at the 12-month time point to be run concurrently, isolated spermatocytes were stored at −80°C, in PBS containing phosphatase inhibitor cocktail, protease inhibitor cocktail, and 10% dimethyl sulfoxide. Cells were thawed and resuspended in filtered 0.1M sucrose with fresh protease inhibitor cocktail, and the cell suspension was immediately dropped onto Superfrost microscope slides (ThermoFisher Scientific), precoated with an even layer of 1% paraformaldehyde and 0.1% Triton X-100. Slides were air-dried for 2 h, washed in 0.4% Photo-Flo Solution (Kodak Professional, NY), and air-dried.
Immunostaining was carried out by first washing slides with buffer (3% BSA in PBS/0.015% Triton-X 100 [PBS-TX]) followed by blocking in antibody diluent (10% goat serum, 3%BSA, PBS-TX) for 5 min. Slides were incubated with primary antibodies, anti-γH2A.X (1:500) and anti-SCP3 (1:500), for 1 h at room temperature, washed in buffer, and reblocked. Appropriate secondary antibodies were added to slides for 1.5 h at room temperature followed by washing in PBS-TX. Slides were mounted in Mowiol, observed under fluorescence as described above, and the number of γH2A.X foci (green staining; Figs. 5A and B) were counted per cell, for 50-100 cells per slide. Anti-γH2A.X labeling of asynapsed sex chromosomes in spermatocytes was excluded from foci counts.
Statistics. Statistical analyses were performed using JMP software Version 9 (SAS Institute, Cary, NC), and detailed statistical output has been included in supplementary data. All body weight, testis weight, water consumption, DNA damage, and meiotic spread data were tested for normality using the Shapiro-Wilk test. When data were not from the Gaussian distribution, the nonparametrical Kruskal-Wallis test was applied for each independent variable separately (acrylamide dose or period of exposure). If a statistically significant difference was found across groups of means, then a post hoc Steel-Dwass multiple comparisons test was used to examine specific significant differences between pairs of groups. Using a two-way mixed model ANOVA, comparisons between acrylamide dose (factor A), period of exposure (factor B), and the interaction between these factors (AB) were also carried out. Additionally, a power analysis was conducted to evaluate the sensitivity of the study to detect the smallest differences between groups. A 5% rejection index of null hypothesis was applied to all tests performed.
RESULTS

Mouse Body Weight, Water Consumption, and Calculated Acrylamide Dose
The initial goal of this study was to establish a chronic exposure mouse model. As such, it was important to establish
FIG. 2.
Histology of testis from control and acrylamide-exposed mice at 10 µg/ml for 12 months. Acrylamide exposure did not induce gross morphological effects in mouse testis after 12 months of acrylamide exposure (0-10 µg/ ml) through the drinking water. Scale bars equal to 100 µm. Note. See online version for color version. the validity of our intervention and to assess the broader consequences for the mice. Individual body weight (g) and water consumption (ml) were monitored for each mouse every second day for the first 3 months of the study. After 3 months of acrylamide exposure, no effects on bodyweight and water consumption were apparent; hence, monitoring of these parameters was carried out on a weekly basis. Table 1 includes the mean bodyweight, the percentage weight difference, and standard deviation (SD) of bodyweight for each treatment group (six mice per group). Significant increases in mouse body weight were found between mice of the 1-month time point compared with mice of other time points (p < 0.05, shown in Supplementary table 3), which was attributable to normal growth of the mice during the study. More importantly, however, the concentration of acrylamide in the drinking water had no significant effect on mouse bodyweight, indicating chronic exposure was not having severe adverse effects on the general well-being of the mice.
Water consumption was monitored throughout the study to ensure the presence of acrylamide in the drinking water did not impact on drinking levels. The mean daily water consumption was recorded per cage and converted to per mouse values. The average water consumption values ranged from 5.4 to 9.7 ml   FIG. 3 . Adduct-related DNA damage in spermatocytes from mice exposed to acrylamide in the drinking water (0-10 µg/ml) over the course of 12 months, as measured by a Comet assay in the presence of FPG. (A) Mean Tail DNA%, expressed as % increase relative to control to enable comparison of data between measurements at different time points. Significant increases in DNA damage were first detected after 6 months at the two highest doses (1 and 10 µg/ml). After 9 and 12 months, increases in DNA damage were observed in doses as low as 0.01 µg/ml compared with respective control data (***p <0.001). Detailed statistical analyses are shown in Supplementary table 5. (B) Representative comet images from control samples, 0.01 µg/ml treatment and the highest 10 µg/ml treatment at the 6-month and 12-month time point. See online version for color version.
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per day (Supplementary table 1) , and a modest increase in the levels of daily water consumption was found for the 1-and 3-month time points compared with all other time points (p < 0.05, Supplementary table 4). However, acrylamide exposure through the drinking water did not significantly affect mouse water consumption, as drinking levels of acrylamide-treated mice were not significantly different from control mice.
The average daily dose (mg/kg bodyweight/day) and total cumulative dose (mg/kg bodyweight) of acrylamide administered to mice were calculated based on water consumption and mouse bodyweight values (Table 2 ). Animals treated with the same concentrations of acrylamide in the drinking water received similar daily doses of acrylamide across all time points. Mice on the 0.01 µg/ml dosing regimen received between 0.001 and 0.002 mg/kg bodyweight/day that is equivalent to the estimated acrylamide intake in humans of 0.001 mg/kg bodyweight/day (WHO, 2011). The 10 µg/ml treatment group at 3 months received the highest daily dose of 2 mg/kg bodyweight/day. This value borders on the NOAEL for acrylamide reproductive toxicity (2-5 mg/kg bodyweight/day). At the two highest doses of 1 and 10 µg/ml, mice received between 0.14 and 2 mg/kg bodyweight/day; and a total cumulative dose of up to 520.1 mg/kg bodyweight. These exposures were in range of the NOAEL and lowest observed adverse effect level for acrylamide neurotoxicity; 0.2-0.5 mg/kg bodyweight/day and 2 mg/kg bodyweight/ day, respectively (Lopachin and Gavin, 2008) . Although testing of neurotoxic defects was not carried out during this experiment; based on visual inspection, no overt effects of neurotoxicity such as hind-limb foot splay were observed in test animals.
Testis to Bodyweight Ratio and Testis Histology
Chronic acrylamide exposure in male mice did not impact severely on testicular weight and histology. At each time point, animals were euthanized, and testes were recovered and weighed. The testis to bodyweight ratio was determined using final mouse bodyweights, and the average testis/bodyweight ratio of each treatment group (six individuals) was calculated. No significant differences in testis/bodyweight ratios were found across different acrylamide doses or across different time points (Supplementary table 2) . Testes were also fixed, sectioned, and hematoxylin and eosin stained in order to examine testis histology (Fig. 2) . No signs of gross morphological changes were found in the testes, even at the highest 10 µg/ml acrylamide dose after 12 months of exposure.
Chronic Acrylamide Exposure In Vivo Generates DNA Damage in Male Germ Cells
Early male germ cells were isolated from the testes of acrylamide-treated mice and assessed for DNA damage. The comet assay was used with the addition of FPG, a restriction enzyme that has previously been used in the comet assay to detect and cleave sites of glycidamide-DNA adducts (Hansen et al., 2010; Thielen et al., 2006) . Significant increases in DNA damage (Tail DNA%) in the FPG-modified comet assay were first observed in mouse spermatocytes following 6 months of chronic acrylamide treatment, at doses of 1 and 10 µg/ml (Fig. 3) . Similar increases were also found in subsequent 9-and 12-month time points, with doses as low as 0.01 µg/ml exhibiting significantly increased levels of DNA damage after 12 months (p < 0.05). The statistical relationship between acrylamide exposure and its effect on Tail DNA was verified across all comet data using a two-way mixed model ANOVA (Supplementary table 5) . Statistical modeling revealed that the factor of exposure time and the interaction of time and acrylamide dose had a significant, positive relationship on germ cell Tail DNA (p < 0.05). Therefore, the results of the comet assay were indicative of a statistically significant, causal relationship between chronic acrylamide exposure in male mice and early germ cell DNA damage.
Sites of DSBs in meiotic cells are associated with surrounding chromatin modifications, such as phosphorylation of histone H2A.X, referred to as γH2A.X (Mahadevaiah et al., 2001) . Investigation of DNA damage was, therefore, carried out using immunohistochemistry on mouse testis sections probed for γH2A.X at the 6-, 9-, and 12-month time points (red staining; Fig. 4 ). Basal expression of γH2A.X in spermatocytes could be observed in control samples; however, γH2A.X staining was more prominent in testes from mice exposed to acrylamide (0.1, 1, and 10 µg/ml), particularly at the two highest doses tested. In these testis sections, γH2A.X expression was predominantly localized to spermatocytes, with modest staining observed in later stage germ cells.
To confirm the presence of DSBs in early male germ cells, isolated spermatocytes from the 12-month time point were further examined using a meiotic spread method. Spermatocytes were spread and fixed onto a microscope slide and visualized using antibodies: anti-γH2A.X (green staining) and anti-SCP3, which labels condensed chromosomes (red staining) (Figs. 5A and B) . DSBs in spermatocytes were quantified by counting the average number of γH2A.X foci per cell (Fig. 5C ). It should be noted that anti-γH2A.X also labels the asynapsed sex chromosomes, as γH2A.X modifications persist in the sex chromosome chromatin throughout meiotic prophase (Mahadevaiah et al., 2001) . Staining of the sex chromosomes (shown in Figs. 5A and B) was not included in γH2A.X foci counts (Figs. 5C and D) .
Male germ cells sustain a number of DSBs during meiosis, due to normal homologous recombination or gene conversion events (Matulis and Handel, 2006) . Therefore, early male germ cells typically exhibit some level of γH2A.X staining that could be observed in control samples of Figures 4 and 5. However, significant increases in the average number of γH2A.X foci were found in spermatocytes from mice exposed to acrylamide for 12 months at all doses (Fig. 5C , p < 0.05). Cells that had more than 50 foci (counted separately, Fig. 5D ) were also found to be more prevalent in spermatocytes from acrylamide-treated mice although this was not statistically significant. Thus, 140 NIXON ET AL.
FIG. 4.
Immunolocalization of γH2A.X, a marker of DSBs, in testis sections from mice exposed to acrylamide in vivo (Control, 0.1, 1, and 10 µg/ml) following 6, 9, and 12 months of exposure. Sections were sequentially probed with anti-cyp2e1 and appropriate secondary antibody before being counterstained with DAPI (shown for control sections). Overall expression of γH2A.X appeared to be upregulated in testis from acrylamide-treated mice compared with control testis sections. Expression of γH2A.X was localized to spermatocytes, with some staining in later stage germ cells, round spermatids. Scale bars equal to 100 µm. See online version for color version.
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141 although a percentage of the observed number of γH2A.X foci are likely representative of normal meiotic recombination, the data presented in Figures 4 and 5 indicated that acrylamide exposure in male mice leads to an increased frequency of DSBs in early male germ cells.
DISCUSSION
The present study is the first to examine the effect of longterm acrylamide exposure in the male, at doses in the range of human exposure levels. Due to the length of the experiment, it was important to establish that mouse weight gain and overall health remained unaffected, particularly in the 10 µg/ml treatment group, which was in range of neurotoxic levels (1.4-2 mg/kg bodyweight/day; Table 2 ). Typical signs associated with acrylamide neurotoxicity such as hind-limb foot splay or muscle weakness have been observed in laboratory animals at repeated daily doses of 0.5-50 mg/kg bodyweight/day (Exon, 2006) . Overt symptoms of acrylamide neurotoxicity were not observed in mice in the current study, though animals were not examined for underlying effects such as peripheral nerve degeneration, which has been reported in rats at doses as low as 0.67 mg/kg bodyweight/day over 2 years (WHO, 2011) .
In regards to reproductive toxicity, the dosing regimen used was lower than that previously found to affect male reproduction in rodents (Tyl and Friedman, 2003) . Thus, effects on fertility rates and dominant lethality, frequently observed at exposures greater than 5 mg/kg bodyweight/day, would not be induced at these levels. However, a more immediate endpoint of DNA damage in male germ cells was the primary focus of this study, as genetic damage in the male germ line could have adverse consequences for the health and development of offspring. Indeed, paternal exposure to acrylamide at high doses (50 mg/ kg bodyweight/day) has been found to produce chromosomally abnormal zygotes and two-cell embryos in mouse breeding studies (Marchetti et al., 2009; Marchetti and Wyrobek, 2005) . Levels of DNA damage were found to increase in spermatocytes of acrylamide-exposed animals in both a dose-and timedependent manner, first observed after 6 months of acrylamide exposure in the FPG-modified Comet assay (Tail DNA%; Fig. 3 ). More importantly, significant increases in DNA damage were apparent by 9 months in the 0.01 µg/ml group that FIG. 5. DSBs observed in spermatocytes from mice exposed to acrylamide in vivo, measured by meiotic spreads and γH2A.X foci counts. (A, B) Representative images of spermatocyte meiotic spreads. SCP3 labels condensed chromosomes; γH2A.X labels both the asynapsed sex chromosomes (arrows) and sites of DSBs (γH2A.X foci, indicated by arrow heads). (A) Spermatocyte with relatively few γH2A.X foci. (B) Spermatocyte exhibiting numerous γH2A.X foci. (C) Mean counts of γH2A.X foci per cell at each dose after 12 months of exposure. Statistically significant increases in DSBs were observed in spermatocytes in all doses compared with control cells (*p < 0.05, ***p < 0.001). Cells with greater than 50 γH2A.X foci were counted separately in (D), which shows mean numbers of cells (> 50 foci) for each dose at the 12-month time point; however, these were not statistically significant. See online version for color version.
received a daily acrylamide dose equivalent to human dietary estimates (1 µg/kg bodyweight/day).
The mechanisms by which acrylamide exerts genotoxicity and DNA damage have not been fully elucidated, though several means of action have been proposed that mostly relate to the adduct chemistry of acrylamide or its metabolite, glycidamide. Acrylamide is described as a soft electrophile that preferentially forms adducts by Michael additions with soft nucleophiles, typically sites of cysteine thiol groups on proteins and glutathione in biological systems (Lopachin and Decaprio, 2005) . Indeed, both acrylamide and glycidamide can cause chromosomal damage through alkylation of protamines, which are necessary proteins in DNA condensation in spermatids and spermatozoa (Sega et al., 1989) . Alternatively, the conjugation of glutathione by acrylamide or glycidamide may deplete cellular glutathione levels essential for the deactivation of reactive oxygen species that can damage DNA. Furthermore, the oxidation of acrylamide to glycidamide may also induce oxidative stress, as the activity of CYP2E1 can lead to the production of free radicals and reactive oxygen species (Cederbaum, 2006) .
However, the metabolism of acrylamide to glycidamide by CYP2E1 may be the most significant mechanism of action as the epoxide, glycidamide, is a hard electrophile that reacts with hard nucleophilic sites, such as the oxygen atoms of purines and pyrimidines (Lopachin and Decaprio, 2005) . Although acrylamide itself reacts slowly with DNA, glycidamide on the other hand directly interacts with DNA and typically produces adducts with guanine, N7-(2-carbamoyl-2-hydroxyethyl)guanine, and to a lesser extent adenine adducts, N3-(2-carbamoyl-2-hydroxyethyl)adenine (Ghanayem et al., 2005a) . Indeed, glycidamide-DNA adducts have been detected via liquid chromatography tandem mass spectrometry in various tissues following acrylamide exposure in rodents (Gamboa da Costa et al., 2003; Watzek et al., 2012) .
The alkaline Comet assay, which was used in the current study, measures DNA strand breaks and alkali-labile sites, a form of genetic damage transformed into strand breaks under alkaline conditions (Singh, 2000) . In vitro studies in mouse testicular cells and V79 cell line cells have demonstrated that the addition of the restriction enzyme, FPG, enhances the sensitivity and specificity of the Comet assay to detect damage following exposure to the acrylamide metabolite, glycidamide (Baum et al., 2008; Hansen et al., 2010; Thielen et al., 2006) . Mice were not exposed to glycidamide in this experiment, as the aim of the study was to simulate chronic acrylamide exposure in humans. However, glycidamide adducts, generated from endogenous metabolism of acrylamide to glycidamide, would be detected using FPG in conjunction with the Comet assay. As stated earlier, acrylamide is unlikely to directly react with DNA, thus it could be said that the DNA damage observed in spermatocytes in Figure 3 is representative of glycidamide-related DNA lesions induced at doses of acrylamide comparable to human exposure levels.
Expression of γH2A.X was also investigated in testis and spermatocytes of acrylamide-exposed mice. The assembly of γH2A.X is thought to have an essential role in the recruitment of DNA-repair proteins and has been used as a marker of DSBs, as it spreads over several megabases from the strand break site (Matulis and Handel, 2006) . Immunohistochemistry of testis sections revealed that overall γH2A.X expression was elevated in acrylamide-treated animals at the 6-, 9-, and 12-month time point (Fig. 4) . Interestingly, this effect appeared to be more pronounced at the higher dose treatments of 1 and 10 µg/ml, which implied a dose-dependent effect. The presence of DSBs was further explored in spermatocytes using meiotic spreads at the 12-month time point. Meiotic spreads have previously been used to study DSBs following γ irradiation in isolated mouse spermatocytes by preparing cell spreads and immunostaining for γH2A.X (Matulis and Handel, 2006) . This was a novel method for examining acrylamide toxicity in male germ cells; and spermatocytes from mice exposed to acrylamide for 12 months were found to have significantly increased frequencies of γH2A.X foci at all doses tested (Fig. 5) .
The data presented herein support the notion that chronic acrylamide exposure leads to increased levels of genetic damage in male germ cells. However, unlike the results of the FPG-modified Comet assay, γH2A.X staining was indicative only of DSBs as opposed to adduct-related DNA lesions. DNA adducts may be resolved into DSB via the activity of repair mechanisms. Therefore, the DSBs observed in meiotic spreads of spermatocytes likely represent a fraction of the range of lesions detected by the Comet assay, suggesting that not all of the genetic damage induced by acrylamide is repaired. This is likely as during spermatogenesis, male germ cells are deficient in certain repair proteins (Olsen et al., 2005) . Spermatogonia carry out numerous mitotic divisions and undergo meiosis to form primary spermatocytes, secondary spermatocytes, and haploid spermatids. Spermatids then undergo spermiogenesis, involving cellular differentiation and extensive chromatin condensation to give rise to spermatozoa. Consequently, male germ cells at different developmental stages of spermatogenesis have varying degrees of susceptibility to DNA damaging agents (Olsen et al., 2005) . The postmeiotic phase is considered to be the most vulnerable to environmental genotoxins, and several studies have demonstrated that the dominant lethal effects of acrylamide act on postmeiotic male germ cells (Favor and Shelby, 2005; Ghanayem et al., 2005b) .
The typical cellular response to irreparable DNA damage is apoptosis, which functions to remove damaged cells from the pool of developing male germ cells (Print and Loveland, 2000) . Acrylamide exposure in rodents has previously been reported to result in germ cell loss, vacuolations in the testis, atrophied seminiferous tubules, and multinucleated germ cells, following oral doses between 20 and 60 mg/kg bodyweight/day (Burek et al., 1980; Hashimoto et al., 1981; Yang et al., 2005) . However, at the chronic exposures used in this study, no gross morphological effects or signs of germ cell apoptosis were observed ACRYLAMIDE INDUCES DNA DAMAGE IN MALE GERM CELLS OF MICE in testis histology of mice (Fig. 2) despite elevated levels of genetic damage in spermatocytes (Figs. 3 and 5) . Therefore, the question remains of whether genetic lesions induced by chronic acrylamide exposure in early male germ cells of mice persist until the point of sperm maturation and downstream fertilization. Indeed, DNA adducts induced by other well-characterized environmental toxicants, such as benzo [a] pyrene, have been demonstrated to accumulate in spermatogenic cells without eliciting apoptosis, and these lesions are not necessarily repaired in the fertilized oocyte (Olsen et al., 2005) . Additionally, several studies have demonstrated that acrylamide exposure at high doses results in heritable damage in specific-locus mutation assays and heritable translocation tests (Favor and Shelby, 2005) . However, it is unknown whether chronic acrylamide exposure at levels of human exposure results in heritable DNA damage, and based on the results of the current study, the answer to the above question remains to be explored.
It was also interesting to note that DNA damage in spermatocytes of acrylamide-exposed mice appeared to accumulate over time . However, male germ cells are continuously generated through the process of spermatogenesis. Spermatocytes examined at the 12-month time point, e.g., would have been generated in the testis (and directly exposed to acrylamide) for a period of only 21 days prior to measurement, as it takes around 42 days for spermatogonia to develop into spermatozoa (Gilbert, 2000) . Several mechanisms may account for this buildup of damage in a self-renewing cell population. Genetic damage induced by acrylamide exposure may accumulate in replicating spermatogonial stem cells, which are responsible for the regeneration of all subsequent germ cell types. Furthermore, long-term, chronic acrylamide exposure may allow for more efficient conversion of acrylamide to glycidamide, subsequently producing more genetic damage over time. Certainly, the internal dose of glycidamide in mice has been found to be greater using lower dosing rates of acrylamide (Doerge et al., 2005) . The factor of age may also contribute to accumulation of DNA damage, as mice were around 18 months old by the end of the study. Indeed, there is strong evidence that common repair mechanisms are diminished in older individuals (Xu et al., 2008) , and thus, chronic acrylamide exposure may be of more consequence to the reproductive health of older males, particularly considering current trends in advanced parental age.
To summarize, we demonstrated that acrylamide exposure via the drinking water, at a range of low-level exposures encompassing human dietary estimates, induces genetic damage in male germ cells of mice. This damage was generated in the absence of major effects on mouse health or defects in spermatogenesis. Additionally, DNA damage appeared to be both dose and time dependent and attributable to a range of genetic lesions arising from either the generation of free radicals via acrylamide metabolism or the formation of DNA adducts by the acrylamide metabolite, glycidamide. Our data indicate that not all of these lesions may be resolved by DNA-repair mechanisms in spermatocytes, and this damage may be exacerbated in older animals, possibly due to reduced efficiency of DNA-repair mechanisms. In conclusion, the results we present here indicate that acrylamide exposure generates male germ line DNA damage at levels equivalent to human dietary intake. As genetic damage in the male germ line may be transmitted to future offspring, we suggest that the genotoxicity of acrylamide be taken into further consideration regarding male reproductive health in humans. 
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